Aptahem appoints new COO
Aptahem (publ) announces today that Maria Ekblad has been appointed new Chief Operating Officer (COO) in the company as of 14 January 2022. Maria has long and solid experience from the pharmaceutical industry where she has held senior management positions within both preclinical and clinical pharmaceutical development. Maria holds a MSc in chemical engineering from Lund University.Maria replaces Ulf Björklund, who due to time limitations, can’t cover the increased activities required when Aptahem becomes a clinical company. Ulf has been the Program Director and COO since 2016 and now takes